Laguna Blends Announces Letter Of Intent with Carlsbad Naturals CBD Bottled Water Company Biotech Investing
Peregrine Pharmaceuticals Reports Top-Line and Initial Biomarker Data from Phase III SUNRISE Trial of Bavituximab Biotech Investing
FDA Grants Priority Review to Genentech’s Lucentis® Supplemental Biologics License Application for Myopic Choroidal Neovascularization Biotech Investing
BriaCell and BriaPro to Present Preclinical Anti-Cancer Activity and Immunotherapy Findings at SITC 2026Â
